ESC Professional Premium Access

Chronic heart failure - New treatments and trials

Event: ESC Congress 2022
Topic: Chronic Heart Failure
Session type: Moderated ePosters
Date: 27 August 2022
Time: 14:15 - 14:45

Congress Session

5 presentations in this session

The I4RON-HF study, Intravenous Iron Isomaltoside for Inpatients veRsus Outpatient Asians with Heart Failure

Speaker: Doctor T. Lee (Kuala Lumpur, MY)
Thumbnail

The effects of combined hyperbaric oxygenation and erythropoietin therapy in treatment of heart failure

Speaker: Professor P. Mitrovic (Belgrade, RS)
Thumbnail

Myeloperoxidase as therapeutic target in HFpEF

Speaker: Doctor S. Lejeune (Brussels, BE)
Thumbnail

First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure - impact on diastolic function

Speaker: Doctor H. Bahrami (Copenhagen, DK)
Thumbnail

Chronic mitochondrial fusion promotor as a novel pharmacological intervention to alleviate left ventricular dysfunction in rats with chronic myocardial infarction

Speaker: Doctor C. Maneechote (Chiang Mai, TH)
Thumbnail

5 speakers from this session

Doctor Tjen Jhung Lee

National Heart Institute, Kuala Lumpur (Malaysia)
0 follower

Professor Predrag Mitrovic

School of Medicine, Belgrade University, Belgrade (Serbia)
0 follower

Doctor Sibille Lejeune

Cliniques Saint-Luc UCL, Brussels (Belgium)
0 follower

Doctor Hashmat Bahrami

Hvidovre Hospital, Copenhagen (Denmark)
0 follower

Doctor Chayodom Maneechote

Chiang Mai University, Chiang Mai (Thailand)
0 follower

This platform is supported by

logo Novo Nordisk